(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDE4B mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:733361 6480464 Demecolcine results in increased expression of PDE4B mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO RGD:11065 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDE4B mRNA CTD PMID:36331819 1,2-dichloroethane affects expression ISO RGD:11065 6480464 ethylene dichloride affects the expression of PDE4B mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:11065 6480464 1, 2-Dimethylhydrazine results in increased expression of PDE4B mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:733361 6480464 Dinitrochlorobenzene results in increased expression of PDE4B mRNA CTD PMID:17374397 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PDE4B mRNA CTD PMID:30723492 17beta-estradiol affects expression ISO RGD:733361 6480464 Estradiol affects the expression of PDE4B mRNA CTD PMID:14699072 17beta-estradiol decreases expression ISO RGD:733361 6480464 Estradiol results in decreased expression of PDE4B mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:733361 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of PDE4B mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of PDE4B mRNA CTD PMID:20404318 , PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:11065 6480464 2 more ... CTD PMID:25510870 , PMID:32352317 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:11065 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11065 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PDE4B mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PDE4B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDE4B mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11065 6480464 Tetrachlorodibenzodioxin affects the expression of PDE4B mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PDE4B mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11065 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDE4B mRNA CTD PMID:17337447 , PMID:19770486 2-butoxyethanol decreases expression ISO RGD:11065 6480464 n-butoxyethanol results in decreased expression of PDE4B mRNA CTD PMID:19812364 3',5'-cyclic AMP multiple interactions ISO RGD:733361 6480464 [Bresol results in decreased activity of PDE4B protein] which results in increased abundance of Cyclic AMP, Cyclic AMP inhibits the reaction [DISC1 protein binds to PDE4B protein] CTD PMID:16293762 , PMID:21854221 3',5'-cyclic AMP multiple interactions ISO RGD:11065 6480464 [[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein], [S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP CTD PMID:21266552 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:11065 6480464 1-Methyl-3-isobutylxanthine results in increased expression of PDE4B mRNA CTD PMID:20711499 3H-1,2-dithiole-3-thione affects expression EXP 6480464 1, 2-dithiol-3-thione affects the expression of PDE4B mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:11065 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PDE4B mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PDE4B mRNA CTD PMID:26186136 4,4'-sulfonyldiphenol increases expression ISO RGD:11065 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PDE4B mRNA CTD PMID:30951980 , PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:11065 6480464 Fenretinide results in increased expression of PDE4B mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:733361 6480464 Decitabine affects the expression of PDE4B mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733361 6480464 [Decitabine co-treated with Vorinostat] affects the expression of PDE4B mRNA CTD PMID:17330099 acrylamide increases expression ISO RGD:11065 6480464 Acrylamide results in increased expression of PDE4B mRNA CTD PMID:30807115 acrylamide decreases expression ISO RGD:733361 6480464 Acrylamide results in decreased expression of PDE4B mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:733361 6480464 Aflatoxin B1 results in decreased methylation of PDE4B gene CTD PMID:27153756 albuterol multiple interactions ISO RGD:733361 6480464 [Albuterol co-treated with Rolipram] results in increased expression of PDE4B mRNA CTD PMID:10763856 all-trans-retinoic acid decreases expression ISO RGD:733361 6480464 Tretinoin results in decreased expression of PDE4B mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:733361 6480464 Tretinoin results in increased expression of PDE4B mRNA CTD PMID:33167477 allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 , PMID:33396045 antirheumatic drug decreases expression ISO RGD:733361 6480464 Antirheumatic Agents results in decreased expression of PDE4B mRNA CTD PMID:24449571 arsane decreases expression ISO RGD:733361 6480464 Arsenic results in decreased expression of PDE4B mRNA CTD PMID:16835338 arsane decreases expression ISO RGD:11065 6480464 Arsenic results in decreased expression of PDE4B mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:733361 6480464 Arsenic results in decreased expression of PDE4B mRNA CTD PMID:16835338 arsenic atom decreases expression ISO RGD:11065 6480464 Arsenic results in decreased expression of PDE4B mRNA CTD PMID:19654921 arsenite(3-) increases expression ISO RGD:11065 6480464 arsenite results in increased expression of PDE4B mRNA CTD PMID:33053406 arsenous acid decreases expression ISO RGD:733361 6480464 Arsenic Trioxide results in decreased expression of PDE4B mRNA CTD PMID:15761015 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of PDE4B mRNA CTD PMID:19541795 Bardoxolone methyl decreases activity ISO RGD:733361 6480464 bardoxolone methyl results in decreased activity of PDE4B protein CTD PMID:28790194 benzo[a]pyrene decreases expression ISO RGD:11065 6480464 Benzo(a)pyrene results in decreased expression of PDE4B mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:733361 6480464 Benzo(a)pyrene affects the methylation of PDE4B 5' UTR, Benzo(a)pyrene affects the methylation of PDE4B promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733361 6480464 Benzo(a)pyrene results in increased expression of PDE4B mRNA CTD PMID:22316170 benzo[e]pyrene increases methylation ISO RGD:733361 6480464 benzo(e)pyrene results in increased methylation of PDE4B intron CTD PMID:30157460 bisphenol A increases expression ISO RGD:11065 6480464 bisphenol A results in increased expression of PDE4B mRNA CTD PMID:21932408 , PMID:32156529 bisphenol A multiple interactions ISO RGD:733361 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PDE4B gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:733361 6480464 bisphenol A results in increased methylation of PDE4B gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:11065 6480464 bisphenol A results in decreased expression of PDE4B mRNA CTD PMID:35479511 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PDE4B mRNA CTD PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PDE4B mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:11065 6480464 bisphenol F results in increased expression of PDE4B mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PDE4B mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:733361 6480464 butyraldehyde results in decreased expression of PDE4B mRNA CTD PMID:26079696 calcitriol increases expression ISO RGD:733361 6480464 Calcitriol results in increased expression of PDE4B mRNA CTD PMID:16002434 , PMID:26485663 carbon nanotube affects expression ISO RGD:11065 6480464 Nanotubes, Carbon analog affects the expression of PDE4B mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:11065 6480464 Nanotubes, Carbon results in increased expression of PDE4B mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:11065 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:733361 6480464 CGP 52608 promotes the reaction [RORA protein binds to PDE4B gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:11065 6480464 Chlorpyrifos results in increased expression of PDE4B mRNA CTD PMID:32715474 ciguatoxin CTX1B affects expression ISO RGD:11065 6480464 Ciguatoxins affects the expression of PDE4B mRNA CTD PMID:18353800 cimetidine multiple interactions ISO RGD:733361 6480464 Cimetidine inhibits the reaction [Histamine results in increased expression of PDE4B mRNA] CTD PMID:11131300 cisplatin increases expression ISO RGD:733361 6480464 Cisplatin results in increased expression of PDE4B mRNA CTD PMID:27594783 cisplatin affects expression ISO RGD:733361 6480464 Cisplatin affects the expression of PDE4B mRNA CTD PMID:23300844 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PDE4B protein CTD PMID:20222156 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PDE4B mRNA, Clozapine results in increased expression of PDE4B protein CTD PMID:18222493 colforsin daropate hydrochloride increases expression ISO RGD:733361 6480464 Colforsin results in increased expression of PDE4B mRNA CTD PMID:15967414 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of PDE4B mRNA CTD PMID:18480146 crocidolite asbestos increases methylation ISO RGD:733361 6480464 Asbestos, Crocidolite results in increased methylation of PDE4B gene CTD PMID:29523930 cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 , PMID:33396045 cytarabine increases expression ISO RGD:733361 6480464 Cytarabine results in increased expression of PDE4B mRNA CTD PMID:21198554 dextran sulfate multiple interactions ISO RGD:11065 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE4B mRNA, PDE4B protein affects the reaction [APC protein affects the susceptibility to Dextran Sulfate] CTD PMID:29950665 , PMID:30188895 diarsenic trioxide decreases expression ISO RGD:733361 6480464 Arsenic Trioxide results in decreased expression of PDE4B mRNA CTD PMID:15761015 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PDE4B mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:11065 6480464 Oxygen deficiency results in increased expression of PDE4B mRNA CTD PMID:16373842 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of PDE4B protein CTD PMID:18941502 dioxygen multiple interactions ISO RGD:11065 6480464 Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of PDE4B mRNA] CTD PMID:16373842 dipyridamole increases expression ISO RGD:11065 6480464 Dipyridamole results in increased expression of PDE4B mRNA CTD PMID:20711499 dorsomorphin multiple interactions ISO RGD:733361 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:11065 6480464 Doxorubicin results in increased expression of PDE4B mRNA CTD PMID:19277126 doxorubicin decreases expression ISO RGD:733361 6480464 Doxorubicin results in decreased expression of PDE4B mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PDE4B mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:733361 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE4B mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:733361 6480464 entinostat results in decreased expression of PDE4B mRNA CTD PMID:26272509 ethanol affects response to substance ISO RGD:733361 6480464 PDE4B gene SNP affects the susceptibility to Ethanol CTD PMID:18438686 ethanol affects splicing ISO RGD:11065 6480464 Ethanol affects the splicing of PDE4B mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PDE4B mRNA CTD PMID:20655511 ethyl methanesulfonate increases expression ISO RGD:733361 6480464 Ethyl Methanesulfonate results in increased expression of PDE4B mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:733361 6480464 PDE4B protein affects the susceptibility to Etoposide CTD PMID:16217747 eugenol increases expression ISO RGD:733361 6480464 Eugenol results in increased expression of PDE4B mRNA CTD PMID:17374397 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 , PMID:33396045 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of PDE4B mRNA CTD PMID:23962444 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of PDE4B protein CTD PMID:20222156 fluoxetine affects expression EXP 6480464 Fluoxetine affects the expression of PDE4B mRNA CTD PMID:12504921 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of PDE4B mRNA CTD PMID:22291481 folic acid increases expression ISO RGD:11065 6480464 Folic Acid results in increased expression of PDE4B mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:733361 6480464 Formaldehyde results in increased expression of PDE4B mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:733361 6480464 Formaldehyde results in decreased expression of PDE4B mRNA CTD PMID:20655997 , PMID:27664576 fulvestrant multiple interactions ISO RGD:733361 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PDE4B gene CTD PMID:31601247 furan decreases methylation EXP 6480464 furan results in decreased methylation of PDE4B gene CTD PMID:22079235 Genipin multiple interactions ISO RGD:11065 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] CTD PMID:22687549 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PDE4B mRNA CTD PMID:22061828 , PMID:33387578 gold atom multiple interactions ISO RGD:11065 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of PDE4B mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:11065 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of PDE4B mRNA CTD PMID:19695318 histamine multiple interactions ISO RGD:733361 6480464 Cimetidine inhibits the reaction [Histamine results in increased expression of PDE4B mRNA] CTD PMID:11131300 histamine increases expression ISO RGD:733361 6480464 Histamine results in increased expression of PDE4B mRNA CTD PMID:11131300 hydroquinone decreases expression ISO RGD:733361 6480464 hydroquinone results in decreased expression of PDE4B mRNA CTD PMID:31256213 irinotecan decreases expression ISO RGD:733361 6480464 Irinotecan metabolite results in decreased expression of PDE4B mRNA, Irinotecan results in decreased expression of PDE4B mRNA CTD PMID:15956246 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of PDE4B mRNA CTD PMID:20097248 lipopolysaccharide affects expression ISO RGD:733361 6480464 Lipopolysaccharides affects the expression of PDE4B mRNA CTD PMID:28070326 lipopolysaccharide increases expression ISO RGD:11065 6480464 Lipopolysaccharides results in increased expression of PDE4B mRNA CTD PMID:20384571 more ... lipopolysaccharide multiple interactions ISO RGD:11065 6480464 [[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:20384571 more ... lipopolysaccharide increases expression ISO RGD:733361 6480464 Lipopolysaccharides results in increased expression of PDE4B mRNA CTD PMID:21854221 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:733361 6480464 Bresol inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] more ... CTD PMID:21854221 more ... lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of PDE4B protein CTD PMID:20222156 lithium chloride decreases expression ISO RGD:733361 6480464 Lithium Chloride results in decreased expression of PDE4B mRNA CTD PMID:23527032 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of PDE4B protein CTD PMID:20222156 manganese atom increases expression EXP 6480464 Manganese results in increased expression of PDE4B protein CTD PMID:31161640 manganese atom multiple interactions EXP 6480464 Rolipram inhibits the reaction [Manganese results in increased expression of PDE4B protein] CTD PMID:31161640 manganese(0) multiple interactions EXP 6480464 Rolipram inhibits the reaction [Manganese results in increased expression of PDE4B protein] CTD PMID:31161640 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of PDE4B protein CTD PMID:31161640 mercury dibromide increases expression ISO RGD:733361 6480464 mercuric bromide results in increased expression of PDE4B mRNA CTD PMID:26272509 methamphetamine affects response to substance ISO RGD:733361 6480464 PDE4B gene SNP affects the susceptibility to Methamphetamine CTD PMID:18316681 methapyrilene increases methylation ISO RGD:733361 6480464 Methapyrilene results in increased methylation of PDE4B intron CTD PMID:30157460 methotrexate affects expression ISO RGD:11065 6480464 Methotrexate affects the expression of PDE4B mRNA CTD PMID:18502557 methylmercury chloride increases expression ISO RGD:733361 6480464 methylmercuric chloride results in increased expression of PDE4B mRNA CTD PMID:28001369 N(6)-dimethylallyladenine increases expression ISO RGD:733361 6480464 N(6)-(delta(2)-isopentenyl)adenine results in increased expression of PDE4B mRNA CTD PMID:16129123 nickel atom increases expression ISO RGD:733361 6480464 Nickel results in increased expression of PDE4B mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:733361 6480464 nickel sulfate results in increased expression of PDE4B mRNA CTD PMID:16780908 , PMID:17374397 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PDE4B mRNA CTD PMID:24136188 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of PDE4B mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:11065 6480464 Acetaminophen affects the expression of PDE4B mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PDE4B mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:11065 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PDE4B mRNA] CTD PMID:18700144 PCB138 multiple interactions ISO RGD:11065 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:11065 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDE4B mRNA CTD PMID:36331819 phenformin increases expression EXP 6480464 Phenformin results in increased expression of PDE4B mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:11065 6480464 Phenobarbital results in decreased expression of PDE4B mRNA CTD PMID:19270015 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PDE4B mRNA CTD PMID:19162173 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of PDE4B mRNA CTD PMID:18158353 phenylmercury acetate multiple interactions ISO RGD:733361 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4B mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:11065 6480464 pirinixic acid results in decreased expression of PDE4B mRNA CTD PMID:18445702 , PMID:23811191 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PDE4B mRNA CTD PMID:19162173 progesterone decreases expression ISO RGD:733361 6480464 Progesterone results in decreased expression of PDE4B mRNA CTD PMID:21795739 progesterone increases expression ISO RGD:733361 6480464 Progesterone results in increased expression of PDE4B mRNA CTD PMID:18497975 roflumilast decreases activity ISO RGD:733361 6480464 Roflumilast results in decreased activity of PDE4B protein CTD PMID:15901792 rolipram multiple interactions ISO RGD:733361 6480464 [Albuterol co-treated with Rolipram] results in increased expression of PDE4B mRNA CTD PMID:10763856 rolipram multiple interactions EXP 6480464 Rolipram inhibits the reaction [Manganese results in increased expression of PDE4B protein] CTD PMID:31161640 rolipram multiple interactions ISO RGD:11065 6480464 Rolipram inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] CTD PMID:20384571 rotenone affects expression EXP 6480464 Rotenone affects the expression of PDE4B mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:733361 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of PDE4B mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:733361 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] CTD PMID:35811015 S-adenosyl-L-methioninate multiple interactions ISO RGD:11065 6480464 [[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:21266552 S-adenosyl-L-methionine multiple interactions ISO RGD:11065 6480464 [[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:21266552 SB 431542 multiple interactions ISO RGD:733361 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of PDE4B mRNA CTD PMID:15967596 silicon dioxide decreases expression ISO RGD:11065 6480464 Silicon Dioxide results in decreased expression of PDE4B mRNA CTD PMID:19073995 , PMID:33720480 silicon dioxide increases expression ISO RGD:733361 6480464 Silicon Dioxide results in increased expression of PDE4B mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:11065 6480464 Silver results in decreased expression of PDE4B mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:11065 6480464 Silver results in decreased expression of PDE4B mRNA CTD PMID:27131904 simvastatin multiple interactions ISO RGD:11065 6480464 Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of PDE4B mRNA] CTD PMID:16373842 sodium arsenate increases expression ISO RGD:11065 6480464 sodium arsenate results in increased expression of PDE4B mRNA CTD PMID:21795629 sodium arsenate decreases expression ISO RGD:11065 6480464 sodium arsenate results in decreased expression of PDE4B mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:11065 6480464 sodium arsenite results in increased expression of PDE4B mRNA CTD PMID:36209798 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PDE4B mRNA CTD PMID:25905778 succimer multiple interactions ISO RGD:11065 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDE4B mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE4B mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:733361 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE4B mRNA CTD PMID:26378955 sulforaphane increases expression ISO RGD:733361 6480464 sulforaphane results in increased expression of PDE4B mRNA CTD PMID:26833863 sulforaphane decreases expression ISO RGD:733361 6480464 sulforaphane results in decreased expression of PDE4B mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:733361 6480464 Sunitinib results in increased expression of PDE4B mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:733361 6480464 Tamoxifen affects the expression of PDE4B mRNA CTD PMID:14699072 tamoxifen affects expression ISO RGD:11065 6480464 Tamoxifen affects the expression of PDE4B mRNA CTD PMID:20937368 testosterone multiple interactions ISO RGD:733361 6480464 [FSHB protein co-treated with Testosterone] results in increased expression of PDE4B mRNA CTD PMID:18535249 testosterone enanthate increases expression EXP 6480464 testosterone enanthate results in increased expression of PDE4B mRNA CTD PMID:21427060 , PMID:25603467 tetrachloromethane affects expression ISO RGD:11065 6480464 Carbon Tetrachloride affects the expression of PDE4B mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDE4B mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PDE4B mRNA CTD PMID:31150632 tetracycline increases expression ISO RGD:11065 6480464 Tetracycline results in increased expression of PDE4B mRNA CTD PMID:16917069 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PDE4B mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:11065 6480464 titanium dioxide results in decreased expression of PDE4B mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions ISO RGD:11065 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE4B mRNA CTD PMID:29950665 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of PDE4B mRNA CTD PMID:16979414 torcetrapib increases expression ISO RGD:733361 6480464 torcetrapib results in increased expression of PDE4B mRNA CTD PMID:23228038 trichloroethene decreases expression ISO RGD:11065 6480464 Trichloroethylene results in decreased expression of PDE4B mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PDE4B mRNA CTD PMID:33387578 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of PDE4B mRNA CTD PMID:24136188 trovafloxacin multiple interactions ISO RGD:11065 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PDE4B mRNA CTD PMID:18930950 tunicamycin decreases expression ISO RGD:733361 6480464 Tunicamycin results in decreased expression of PDE4B mRNA CTD PMID:22378314 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PDE4B mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:733361 6480464 Valproic Acid results in increased expression of PDE4B mRNA CTD PMID:24383497 , PMID:28001369 valproic acid decreases expression ISO RGD:733361 6480464 Valproic Acid results in decreased expression of PDE4B mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:733361 6480464 Valproic Acid affects the expression of PDE4B mRNA CTD PMID:25979313 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of PDE4B mRNA CTD PMID:25423262 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PDE4B mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:733361 6480464 Vincristine results in increased expression of PDE4B mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:733361 6480464 [decitabine co-treated with vorinostat] affects the expression of PDE4B mRNA CTD PMID:17330099 zoledronic acid decreases expression ISO RGD:733361 6480464 zoledronic acid results in decreased expression of PDE4B mRNA CTD PMID:24714768